PARP Inhibitors for Metastatic CRPC: More Answers than Questions, a Systematic Review and Meta-Analysis.

Pharmaceuticals (Basel) · 2025 · PMC12298444 · PMID 40732303

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the non-HRRm population, the combination did not reach statistical significance (HR = 0.81; 95% CI: 0.64–1.03; I 2 = 43.9%) ( Figure 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.